FI882705A0 - Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä - Google Patents

Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä

Info

Publication number
FI882705A0
FI882705A0 FI882705A FI882705A FI882705A0 FI 882705 A0 FI882705 A0 FI 882705A0 FI 882705 A FI882705 A FI 882705A FI 882705 A FI882705 A FI 882705A FI 882705 A0 FI882705 A0 FI 882705A0
Authority
FI
Finland
Prior art keywords
aminoacylates
preparation
glycerol acetal
pharmacologically useful
pharmacologically
Prior art date
Application number
FI882705A
Other languages
English (en)
Swedish (sv)
Other versions
FI90421C (fi
FI90421B (fi
FI882705A (fi
Inventor
Colette Broquet
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of FI882705A0 publication Critical patent/FI882705A0/fi
Publication of FI882705A publication Critical patent/FI882705A/fi
Application granted granted Critical
Publication of FI90421B publication Critical patent/FI90421B/fi
Publication of FI90421C publication Critical patent/FI90421C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI882705A 1987-06-12 1988-06-08 Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä FI90421C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878713745A GB8713745D0 (en) 1987-06-12 1987-06-12 Aminoacylates of glycerol
GB8713745 1987-06-12

Publications (4)

Publication Number Publication Date
FI882705A0 true FI882705A0 (fi) 1988-06-08
FI882705A FI882705A (fi) 1988-12-13
FI90421B FI90421B (fi) 1993-10-29
FI90421C FI90421C (fi) 1994-02-10

Family

ID=10618794

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882705A FI90421C (fi) 1987-06-12 1988-06-08 Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä

Country Status (33)

Country Link
US (1) US4921865A (fi)
JP (1) JPH0615540B2 (fi)
KR (1) KR960005153B1 (fi)
AR (1) AR245121A1 (fi)
AT (1) AT396236B (fi)
AU (1) AU621298B2 (fi)
BE (1) BE1000700A4 (fi)
CA (1) CA1337297C (fi)
CH (1) CH674516A5 (fi)
DE (1) DE3819829C2 (fi)
DK (1) DK319188A (fi)
DZ (1) DZ1215A1 (fi)
ES (1) ES2009283A6 (fi)
FI (1) FI90421C (fi)
FR (2) FR2616326B1 (fi)
GB (1) GB8713745D0 (fi)
GR (1) GR1000889B (fi)
HK (1) HK77191A (fi)
IE (1) IE61447B1 (fi)
IN (1) IN172782B (fi)
IT (1) IT1218067B (fi)
LU (1) LU87235A1 (fi)
MA (1) MA21298A1 (fi)
MY (1) MY103577A (fi)
NL (1) NL192521C (fi)
NO (1) NO170632C (fi)
NZ (1) NZ224936A (fi)
OA (1) OA08879A (fi)
PT (1) PT87689B (fi)
SE (1) SE466450B (fi)
SG (1) SG73191G (fi)
TN (1) TNSN88057A1 (fi)
ZA (1) ZA884024B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035178A (en) * 1976-08-31 1977-07-12 Fmc Corporation Herbicidal 1,3-dioxanes
IN146343B (fi) * 1976-08-31 1979-05-05 Fmc Corp
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters

Also Published As

Publication number Publication date
DK319188A (da) 1989-02-03
MY103577A (en) 1993-08-28
IN172782B (fi) 1993-11-27
PT87689B (pt) 1992-09-30
NO882564L (no) 1988-12-13
GR1000889B (el) 1993-03-16
SE8802162L (sv) 1988-12-13
FR2616326B1 (fr) 1989-12-01
AU1756288A (en) 1988-12-15
SG73191G (en) 1991-11-22
NO170632C (no) 1992-11-11
AU621298B2 (en) 1992-03-12
FI90421C (fi) 1994-02-10
NO170632B (no) 1992-08-03
SE8802162D0 (sv) 1988-06-09
DZ1215A1 (fr) 2004-09-13
DK319188D0 (da) 1988-06-10
HK77191A (en) 1991-10-11
TNSN88057A1 (fr) 1990-07-10
NZ224936A (en) 1990-03-27
BE1000700A4 (fr) 1989-03-14
ATA152988A (de) 1992-11-15
FR2616432B1 (fr) 1990-05-11
NL192521C (nl) 1997-09-02
AR245121A1 (es) 1993-12-30
US4921865A (en) 1990-05-01
KR960005153B1 (ko) 1996-04-22
SE466450B (sv) 1992-02-17
FI90421B (fi) 1993-10-29
OA08879A (fr) 1989-10-31
LU87235A1 (fr) 1988-12-13
JPH0615540B2 (ja) 1994-03-02
NO882564D0 (no) 1988-06-10
GB8713745D0 (en) 1987-07-15
KR890000471A (ko) 1989-03-14
IE61447B1 (en) 1994-11-02
FR2616432A1 (fr) 1988-12-16
AT396236B (de) 1993-07-26
NL8801484A (nl) 1989-01-02
PT87689A (pt) 1988-07-01
MA21298A1 (fr) 1988-12-31
IT8820940A0 (it) 1988-06-10
IE881752L (en) 1988-12-12
CH674516A5 (fi) 1990-06-15
IT1218067B (it) 1990-04-12
DE3819829C2 (de) 1993-10-21
ES2009283A6 (es) 1989-09-16
FR2616326A1 (fr) 1988-12-16
CA1337297C (en) 1995-10-10
NL192521B (nl) 1997-05-01
GR880100363A (en) 1989-03-08
FI882705A (fi) 1988-12-13
DE3819829A1 (de) 1988-12-22
JPS6413085A (en) 1989-01-17
ZA884024B (en) 1989-02-22

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI93350C (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
IS3529A7 (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkum bis-aza-bísýklískum efnasamböndum
PT86687A (pt) Process for the preparation of novel polyamine derivatives
FI890072A (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
PT87315A (pt) Process for the preparation of indolizine indene or azulene derivatives
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI882669A (fi) Menetelmä farmaseuttisesti aktiivisten alfa-halogenoitujen dikarboksyylihappojen valmistamiseksi
FI883997A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
PT87854A (pt) Process for the preparation of thio-urea derivatives
IT8419141A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina.
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
ES2022952B3 (es) Proceso para la preparacion de naftacenos
FI94348C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten bis-aryylifosfaattiesterijohdannaisten valmistamiseksi
FI882705A0 (fi) Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI893478A (fi) Menetelmä uusien kysteiinijohdannaisten valmistamiseksi
IT8321080A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION